The rising adoption of GLP-1 receptor agonists (RAs) is triggering a major pivot in the food and supplement sectors, as manufacturers race to develop companion products for weight-loss patients. Approximately 12% of U.S. adults have utilized these therapies, according to industry data. Experts from companies like Gnosis by Lesaffre, Kerry, and ADM report that this shift is moving beyond simple weight management toward holistic metabolic wellness, focusing on nutrient density, satiety signaling, and muscle preservation for both active and post-GLP-1 users.
How are food companies adapting to GLP-1 users?
Food and beverage companies are reformulating products to provide “clinical-adjacent nutrition” that fits the specific needs of patients on GLP-1 medications. According to Vivien Sheehan, VP of Business Development at Kerry, the most successful brands are those that maintain the pleasure of eating while addressing health goals. Research from Kerry indicates that the top formats favored by these consumers include yogurt, protein bars, and fresh produce. Because only 6% of GLP-1 users intend to stay on the medication for life, brands are prioritizing products that support long-term habits, such as high-protein ready-to-drink beverages and fiber-rich snacks.
What role do supplements play in GLP-1 therapy?
Supplements are increasingly viewed as essential companion products to mitigate common side effects and optimize therapy outcomes. Silvia Pisoni, global operational marketing director at Gnosis by Lesaffre, notes that 99% of GLP-1 users fall below recommended intake levels for vitamin K, a nutrient critical for bone and artery health. Furthermore, users often face muscle loss and gastrointestinal distress. Pisoni recommends that consumers utilize whey protein, creatine monohydrate, and beta-hydroxy-beta-methylbutyrate (HMB) to preserve lean body mass. When developing these products, Pisoni warns that manufacturers must be transparent about potential stomach upset, as the medication can exacerbate gut sensitivity.
How can metabolic health be maintained after stopping medication?
Maintaining weight loss after ending GLP-1 therapy remains a primary challenge, as research shows up to two-thirds of lost weight can return within a year. Alicia Humpert, global marketing director of Microbiome at ADM, states that biotics and prebiotic fibers are key to supporting metabolic health during this transition. ADM’s BPL1 postbiotic is specifically designed to target visceral fat and waist circumference. Additionally, ingredients like Fibersol can increase appetite-regulating hormones when consumed at 10 grams per meal, helping users manage satiety naturally as the effects of the medication fade.
Understanding the GLP-1 consumer segments
Not all GLP-1 users have the same needs, and companies are segmenting their strategies accordingly. Kerry’s research identifies five distinct groups, ranging from “Dynamic Dads,” who prioritize high-energy support, to “Balanced Maintainers,” who focus on long-term, practical health strategies. By tailoring formulations to these specific demographics, manufacturers can improve patient adherence and trust. Maggie McNamara, VP of Global Marketing at Saanroo, emphasizes that this sector must be built on clinical rigor rather than marketing hype. Success depends on products that genuinely assist users in navigating changing nutritional needs as their metabolic profiles evolve.
Did you know?
Beyond weight loss, GLP-1 RAs are being investigated for their potential to reduce chronic inflammation and treat neurodegenerative diseases, according to Gnosis by Lesaffre.
Frequently Asked Questions
- Why is muscle loss a concern for GLP-1 users? Rapid weight loss caused by these medications often includes the loss of lean muscle mass. Experts suggest protein supplementation and resistance exercise to counter this effect.
- Are probiotics effective for GLP-1 patients? Yes, but experts like Kerry’s Vivien Sheehan suggest using resilient biotics, such as BC30, which can survive manufacturing processes and remain effective without refrigeration.
- What is the most common nutrient deficiency in GLP-1 users? Data from Gnosis by Lesaffre indicates that nearly all users fall short of vitamin K requirements, which are essential for bone and cardiovascular health.
Are you developing products for the metabolic wellness market? Share your thoughts on the future of functional nutrition in the comments below or subscribe to our newsletter for more industry insights.
Keep reading